To assess the impact of targeting COX4I1 on the maintenance of human leukemia, we transduced a Molm13‐Cas9+/Luc+ human acute myeloid leukemia (AML) model[12, 13] with sgCtrl and sgCOX4I1. This evidence concerns the gene COX4I1 and acute myeloid leukemia.